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Background: Antiretroviral treatment restores physical functioning and may have an impact on fertility desires.
Counseling is given to HIV positive women to create awareness and to provide information on pregnancy and
delivery. The purpose of this study was to determine the incidence of pregnancy and factors that predict
pregnancy among women of reproductive age receiving HIV care and treatment at a large urban center in western
Uganda.
Methods: We conducted a retrospective cohort study using routinely collected data at the Immune Suppression
(ISS) Clinic of Mbarara Regional Referral Hospital located in Mbarara District, western Uganda collected between
January 2006 and June 2010. Women aged 15 to 50 years were eligible for analysis. The primary outcome was
incidence of pregnancy calculated as number of pregnancies per 1000 person years (PY). Data was analyzed by
calendar year and year of enrolment and used survival analysis to determine the predictors of pregnancy.
Results: A total of 3144 women were included with a median follow up of 12.5 months. The overall incidence rate
was 90.7 pregnancies per 1000 person years. Incidence increased from 29.8 pregnancies per 1000 PY in 2006 to 122
pregnancies per 1000 PY in 2010 (p < 0.001). Significant predictors for pregnancy were younger age (HR 10.96 95% CI
3.22-37.2), married (HR 2.09 95% CI 1.69-2.64) and single (HR 1.95 95% CI 1.34-2.84) compared to widowed or separated,
primary education (HR 1.65 95% CI 1.02-2.66), not knowing the HIV status of the spouse (HR 1.46, 95%CI 1.13-1.93)
compared to knowing. The use of family planning (HR 0.23 95% CI 0.18- 0.30) and an increase in CD4 count between
baseline and most recent count were protective against pregnancy. ART use was not a significant predictor.
Conclusion: Incidence of pregnancy among women receiving routine HIV care and treatment has increased and is
almost comparable to that in the general population. Thus routine HIV care should integrate reproductive health needs
for these women.Introduction
Antiretroviral therapy (ART) is now widely available in
resource limited settings following major large scale ini-
tiatives [1-4] and the treatment significantly improves
the physical functioning [5-7] and sexual activity [8] of
HIV infected patients. For HIV infected women, the
prospects of getting pregnant and having an HIV nega-
tive baby will be significantly improved with the increas-
ing availability of ART, because of its association with a
reduction in the risk of mother to child transmission of* Correspondence: fbaj@yahoo.com
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unless otherwise stated.HIV [9-11]. This may result in an increasing trend in in-
cidence of pregnancy among HIV infected women. How-
ever, studies on fertility and HIV in sub Saharan Africa
have shown that HIV infection is associated with re-
duced fertility [12-14] and that ART may have a poten-
tial impact on the fertility [15].
Recent studies from sub Saharan Africa have shown
that HIV positive women are less likely to report fertility
intentions compared to HIV negative women [16,17],
however there were no differences observed in child
bearing desire between ART treated and naïve women.
Prospective studies have shown that reproductive inten-
tions and desires differ significantly from practices with. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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have, especially following initiation of ART [18].
HIV infection in pregnancy is associated with a variety
of complications. For instance, HIV infection is associ-
ated with adverse pregnancy outcomes and substantial
maternal mortality even among women with high CD4
count [19], despite the availability of ART. Maternal mor-
tality rates have been reported to be five times higher in
HIV infected women than in uninfected women and re-
sponsible for at least 20% of all deaths, a figure that is
higher than any direct obstetric cause [20]. Recent data
has also shown an increased risk of female to male HIV
transmission during pregnancy, suggesting pregnancy as a
risk factor for transmission of HIV [21].
The potential complications and risks necessitate a
clear understanding of the trends and patterns in occur-
rence of pregnancy among HIV infected women. Clini-
cians and counselors at the clinics also need to identify
women that are more likely to get pregnant and target
them for counseling and guidance on safe pregnancy
and prevention of mother-to-child transmission of HIV.
Therefore, the aim of this study was to determine the in-
cidence rate and predictors of pregnancy among HIV
positive women of reproductive age attending a large
urban HIV clinic at Mbarara Regional referral Hospital
in southwestern Uganda.
Methods
We constructed a retrospective cohort using routine re-
cords collected at the Immune suppression (ISS) clinic
at Mbarara Regional Referral hospital (MRRH) located
in Mbarara District in southwestern Uganda. The district
is predominantly rural, with large majority earning a liv-
ing as subsistence farmers. The regional referral facility
is also the teaching hospital for Mbarara University of
Science and Technology’s medical school. Data used for
this study was collected routinely from patients attending
their monthly visits to collect medicine refills at the ISS
clinic at Mbarara Hospital. Analysis of data for this paper
was restricted to women of reproductive age (15–50 years)
enrolled into HIV care or ART treatment between June
2006 and January 2010.
History taken at every routine visit includes sexual activ-
ity, determination of the date of last normal menstruation
period (LNMP) and clinical examination. The primary
outcome for this study was incidence of pregnancy. Preg-
nancy was recorded if a clinical diagnosis based on history
and examination was made during the follow up visits and
entered into the records. The date pregnancy occurred
was calculated to be date of the last normal menstrual
period. All the subsequent visits following the pregnancy
diagnosis were censored in the analysis.
The independent variables considered in the analysis
were age, educational status, weight, religion, monthlyincome, marital status, occupation, total number of chil-
dren, disclosure of HIV sero-status, use of PMTCT ser-
vices, HIV status of the spouse, family planning use and
method, ART initiation date and duration of use, reli-
gion, WHO disease stage and CD4 cell count. Three data
sets were extracted; the first set comprised of constant var-
iables such as educational status and occupation, the sec-
ond had time varying variables such as weight and the last
had CD4 count measures for the follow up period. The
three data sets were cleaned and merged together for
final analysis.
Data analysis
Frequency distributions were used to summarize data on
the categorical variables and some variables like age,
family size, and education level were grouped into cat-
egories before the frequencies were generated. Means
and medians were used to summarize the continuous
variables. We considered change in CD4 count as an ex-
posure factor and calculated the absolute change in CD4
count between measures at baseline and the most re-
cent. The incidence of pregnancy was measured as num-
ber of pregnancy events per 1000 person years (PY). We
used Poisson regression to estimate the incidence rates.
Survival analysis with parametric survival-time models
were used to obtain crude and adjusted hazard ratios for
the predictor variables with 95% confidence intervals.
Women were censored after their first reported preg-
nancy as clients in the ART clinic. The exposure vari-
ables considered in the analysis were use of ART, marital
status, disclosure, number of children and their HIV sta-
tus, and use of contraception. We calculated incidence
rates of pregnancy over the calendar years of follow up
and tested for the trends in incidence using the chi
square test for trend. All the analyses were done using
Stata Version 11.
Ethical considerations
The study was approved by the ISS clinic data sharing
committee, the Faculty of Medicine Research ethics
committee and the Institutional review Board of Mbarara
University of Science and Technology. All the datasets ex-
tracted from the Open electronic Medical Records System
(OMRS) database were stored with password access and
codes were used instead of names and all the information
was kept confidential.
Results
Baseline characteristics of participants
Data was extracted for a total of 5,407 women. Of these,
1680 women had missing data on pregnancy status and
583 were missing data on date of enrollment and were
removed from the analysis. Hence 3,144 women had
complete data and were considered for the final analysis.
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follow up ranged from 0 to 49 months, with an average
follow up of 15 months (standard deviation, SD = 11,
median = 12.5). The mean age was 33 years (SD = 9.3,
median = 32) and more than 50% had attained primary
school education (Tables 1 and 2). Peasant farmers con-
stituted up to 37.3% of the women. Most of these
women were low income earners and 56.9% earned less
than 100,000 Uganda shillings (40USD) at the time of
clinic enrollment. Only about one quarter (27.3%) of the
women had disclosed their HIV serostatus but more than
50% of the women had their disclosure status unknown.
Incidence of pregnancy
Women were followed up between June 2006 and January
2010. During this period, total of 36,775 visits for the
3,144 women were entered in the database. In this period,
462 (15%) women experienced a pregnancy event. The
mean time to a pregnancy event was 16 months.
Seventy five pregnancies occurred among women en-
rolled in 2006, 175 among women enrolled in 2007, 136
pregnancies in 2008, 76 pregnancies in 2009 and no
pregnancies among women enrolled in 2010 (Figure 2a).
The overall pregnancy incidence rate was 90.8 pregnan-
cies per 1000 person years (PY) with 95% CI 82.9 – 99.5.
The incidence rates per 1000 PY by year of enrollment
were 63, 91.3, 100, 125 and 0 for 2006 to 2010 respect-
ively. The incident rates per 1000 PY by calendar year
were 29.9, 52.8, 87.4, 100.7 and 122.6 for 2006 to 2010 re-
spectively (Figure 2b).
We tested for cohort effects in this clinic population by
examining incidence of pregnancy by the year of enroll-
ment, considering each group of women in the same year
of enrollment as a cohort. There was no significant trend
in incidence of pregnancy (Figure 2a). However, the inci-
dence rate of pregnancy by calendar year increased signifi-
cantly over time (Figure 2b) and chi square test for trend
p value <0.0.001. These annual incidence rates were5407 women
Total clinic popu
1680 (31%), dropped due to 
missing pregnancy data
583 (15.6%)  were dr
due to missing data o
of enrollment
Figure 1 Figure showing the flow chart of women enrolled at the clincalculated for all women during the calendar year within
which they occurred, regardless of the year of enrollment.Predictors of pregnancy
The women aged less than 18 years (HR 10.9 95% CI
3.22-37.15, p < 0.0001) and those aged 18–24 years
(HR = 9.93, CI 6.1-16.1, p < 0.0001) were more likely to
become pregnant compared to those aged 39 years and
above (Table 3). Other factors associated with an increased
risk of pregnancy include being single or married, less
years of education i.e., having attended primary school
education only, unemployed and peasant farmers. Women
in a lower income bracket as measured by a monthly in-
come less than 100,000 Uganda shillings (40 USD) or
women who did not know their spouse’s HIV serostatus
were also more likely to become pregnant compared to
the women in the higher income bracket and those who
knew their spouse’s HIV serostatus.
Factors associated with a decreased risk of pregnancy
include having ever used any method of family planning
(HR = 0.23, CI = 0.18- 0.30, p < 0.0001) and increase of
100 or more in CD4 (CD4 difference) between baseline
and most recent CD4 measure. The Kaplan Meier sur-
vival curves for women who had ever used and those
that had not were significantly different, with a log rank
test of p value <0.0001 (Figure 3). The graph shows that
by the end of the follow up period, about 80% of the
women who had ever used any family planning method
were still not pregnant compared to about 60% among
those who never used family planning. Women who
were married or single were more likely to become preg-
nant compared to those who were separated or divorced
(Table 3). For CD4 count, we compared the baseline
measurement with the most recent measure and com-
puted the difference. A CD4 difference of 350 or above
was associated with lower incidence of pregnancy with







ic and those included in the final analysis.
Table 1 Baseline demographic characteristics of women of reproductive age attending Mbarara ISS clinic
Variable Pregnant (n = 462) Not pregnant (n = 2,682) Total (n = 3,144)
Age (years)
39 and above 21 (4.6) 671 (25.0) 692 (22.0)
32 -38 97 (21) 703 (26.2) 800 (25.1)
25 -31 208 (45.2) 820 (30.6) 1,028 (32.7)
18 – 24 133 (28.79) 477 (17.8) 610 (19.4)
Below 18 3 (0.65) 11 (0.04) 14 (0.45)
Education level
Tertiary 18 (3.9) 165 (13.2) 183 (5.8)
Secondary 84 (18.2) 440 (16.4) 524 (16.7)
Primary 282 (61.0) 1,438 (53.6) 1,720 (54.7)
None 44 (9.5) 284 (10.6) 328 (10.4)
Unknown 34 (7.4) 355 (13.2) 389 (12.4)
Occupation
Formal employment 86 (18.6) 559 (20.8) 645 (20.5)
Unemployed 95 (20.6) 538 (20.1) 633 (20.1)
Peasant farmer 180 (38.9) 992 (40.0) 1,172 (37.3)
Others 59 (12.8) 314 (11.7) 373 (11.9)
Unknown 42 (9.1) 279 (10.4) 321 (10.2)
Income
Above 500,000 8 (1.2) 47 (1.75) 55 (1.75)
100,000 - 500,000 20 (4.3) 221 (8.2) 241 (7.7)
Less than 100,000 263 (56.9) 1,538 (57.4) 1,801 (57.3)
Unknown 171 (37) 876 (32.6) 1,047 (33.3)
Religion
Protestant 219 (47.4) 1,314 (48.9) 1,533 (48.7)
Catholic 128 (27.7) 723 (27.0) 851 (27.1)
Moslem 45 (9.7) 246 (9.2) 291 (9.3)
Seventh day/Pentecostal 5 (1.1) 31 (1.16) 36 (1.2)
Unknown 50 (10.8) 298 (11.1) 348 (11.1)
Others 15 (3.3) 70 (2.6) 85 (2.7)
HIV status of the spouse
Unknown by woman 71 (15.4) 428 (15.9) 499 (15.8)
Negative 15 (3.2) 60 (2.2) 75 (2.5)
Positive 214 (46.3) 1,133 (42.8) 1,347 (42.8)
Missing data 162 (35.1) 1,061 (39.6) 1,223 (38.9)
ART use
Yes 165 (35.7) 1,109 (41.3) 1,274 (40.5)
No 297 (64.3) 1,573 (58.7) 1,870 (59.5)
Disclosure
No 29 (6.3) 236 (8.8) 265 (8.4)
Yes 126 (27.3) 1,075 (40.1) 1,201 (38.2)
Missing data 307 (66.4) 1,371 (51.1) 1,678 (53.4)
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Table 2 Table of family and clinical characteristics of women receiving HIV care and treatment at Mbarara ISS clinic
Variable Pregnant (n = 462) Not pregnant (n = 2,682) Total (n = 3,144)
Total number of children alive
5 and above 274 (59..3) 1,457 (54.3) 1,731 (55.0)
2-5 children 116 (25.1) 892 (33.3) 1008 (32.1)
1 child 72 (15.6) 333 (12.4) 405 (12.9)
Weight (kg)
Less than 50 71 (16.5) 672 (29.4) 743 (27.3)
51 – 60 202 (46.9) 974 (42.6) 1,176 (43.3)
61 -71 110 (25.6) 431 (18.8) 541 (19.9)
Above 71 47 (10.9) 212 (9.3) 259 (9.5)
WHO stage
Stage 1 152 (32.9) 935 (34.9) 1,087 (34.6)
Stage 2 151 (32.7) 806 (30) 957 (30.4)
Stage 3 38 (8.2) 317 (11.8) 355 (11.2)
Stage 4 2 (0.4) 66 (2.5) 68 (2.2)
Missing 119 (25.6) 558 (20.8) 677 (21.5)
Marital status
Married 260 (56.3) 1,034 (38.6) 1,294 (41.2)
Single 38 (8.2) 208 (7.8) 246 (7.8)
Widowed/separated 149 (32.3) 1,344 (50.1) 1,493 (47.5)
Missing data 15 (3.3) 96 (3.6) 111 (3.5)
CD4 count difference between
most recent and baseline measure
Less than 100 58 (12.6) 309 (11.5) 367 (11.7)
100 – 250 8 (1.7) 67 (2.5) 75 (2.4)
250 – 350 2 (0.4) 18 (0.6) 20 (0.6)
Greater than 350 2,288 (85.3) 394 (85.3) 2,682 (85.3)
Family planning use
Yes 70 (15.1) 1,114 (41.5) 1,184 (37.7)
No 339 (73.4) 1,394 (52) 1,733 (55.1)
Missing 53 (11.5) 174 (6.5) 227 (7.2)
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pregnancy include religion, WHO disease stage, ARV
use and CD4 cell count at enrollment. The disclosure of
HIV status was defined as disclosure to any concerned
person and not necessarily their spouse. The results sug-
gest there is a likelihood of a lower incidence of pregnancy
among those with more advanced disease compared to
those in earlier disease stage but the association was not
significant.
We conducted a multiple regression analysis with fam-
ily planning, age, serostatus of spouse, marital status,
education, income and CD4 difference in the model. In
the model, use of family planning, younger age, marital
status, education and CD4 difference remained signifi-
cant predictors of pregnancy.Discussion
Our study uses routinely collected data to measure inci-
dence and predictors of pregnancy among women of re-
productive age attending a large urban HIV clinic serving
a predominantly rural population in western Uganda. The
data shows incidence of pregnancy among these women
has increased consistently for a period of 5 years but is still
lower than 195 per 1000 PY in the general population of
Ugandan women aged between 35 to 39 years [22]. The
increase in incidence of pregnancy has been observed else-
where in rural Uganda [18,23] and these studies confirm
our findings.
The increasing incidence of pregnancy should be of
concern to the clinicians because our data shows at least














































Figure 2 Incidence of pregnancy by year of enrollment (a) and calendar year (b) among women at Mbarara ISS clinic, western Uganda.
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ease when they became pregnant. This increases the risk
of mother-to-child transmission of HIV and necessitates
the early screening and initiation of ART regardless of
the CD4 count as currently recommended in the 2013
WHO guidelines for treatment of pregnant and breast-
feeding mothers [24] and continuation of ART for life
also known as Option B+. Obviously, the implementa-
tion of the program of this nature will require significant
preparations particularly in high burden countries such
as Uganda. There are also likely to be challenges of ad-
herence to treatments among patients who initiate ther-
apy early in the infection and such studies should be
conducted to inform policy on treatment recommenda-
tions when these programs start.
It is difficult to explain why the incidence of pregnancy
is increasing. One of the reasons may be due to ART op-
timism. Success stories of treatment are now ubiquitous
and this may motivate more women to pursue their fer-
tility goals without fear of their health deteriorating.
However, this may not be completely true because our
data shows no difference in incidence of pregnancy
among ART users and non users and a study from rural
Uganda has also shown no difference in fertility desires
among ART users and non users [25,26]. Though our
data did not show any difference in incidence of preg-
nancy among ART users and non-users, the evidence
supporting ART optimism is from a large ART program
implemented in 7 African countries. In this study, inci-
dence of pregnancy among ART users was almost two
fold compared to non ART users [27].Our data may not fully explain the increasing inci-
dence of pregnancy but clearly we are now faced with
the increasing need to integrate reproductive health into
HIV care programs. Care givers will need to assess their
clients’ fertility intentions and incorporate reproductive
counseling into the routine care to cater for their repro-
ductive needs especially as HIV care programs mature
and patients. For instance, less than 40% of the clients
had ever used a family planning method.
Studies also suggest that a majority of pregnancies in
rural Africa are unintended and many HIV infected women
perceive themselves as infertile [28]. This lack of awareness
about fertility potential may be responsible for the large
majority of the unintended pregnancies and hence the lack
of difference in incidence of pregnancy among women re-
ceiving ART compared to those not receiving. Also, a re-
cent clinical trial of pre-exposure prophylaxis among HIV
uninfected women in sero-discordant partnerships also
showed no significant difference in incidence of pregnancy
among women in the placebo and treatment arms [29].
The factors that were associated with incidence of preg-
nancy in our cohort were young age, marital status, lack of
knowledge of spouse HIV serostatus, lower socio eco-
nomic status and use of family planning. These factors are
similar to those that predict pregnancy in the general
population. For instance, younger women were more likely
to get pregnant compared to the older women. This obser-
vation has also been made in previous studies in Africa
[18,27,30]. These observations are expected because
women are generally most fertile between the ages of 20
and 24 years and as they get older the likelihood of getting
Table 3 Rates of pregnancy per 1000 person years with crude hazard ratios for the predictor variables
Factor Number of pregnancies Rates/1000 py Crude HR (95% CI) p-value
Age
39 and above 21 16 1
32 to 38 97 69.5 4.15 (2.52-6.82) <0.001*
25 to 31 208 132.7 8.23 (5.13-13.19) <0.001*
18 to 24 133 168 9.93 (6.10-16.12) <0.001*
Less than 18 3 166 10.9 (3.22-37.15) <0.001*
Marital status
Widowed/separated 149 60.6 1
Single 38 110 1.95 (1.34-2.84) <0.001*
Married 260 125.5 2.09 (1.69-2.69) <0.001*
Education
Tertiary 18 62 1
Secondary 84 99 1.66 (0.56- 1.68) 0.008*
Primary 282 102.4 1.65 (1.02-2.66) 0.039*
None 44 60 1.63 (0.87-3.06) 0.129
Occupation
Employed 86 79.6 1
Unemployed 95 108.5 1.36 (1.02, 1.82) 0.037*
Peasant farming 180 87 1.10 (0.85, 1.43) 0.449
Others 59 99 1.36 (0.89, 1.73) 0.189
Religion
Others 20 88.3 1
Protestant 219 90 1.02 (0.65-1.61) 0.932
Catholic 128 95.3 1.08 (0.67- 1.72) 0.749
Moslem 45 95 1.07 (0.64-1.82) 0.781
Income
500,000 and above 8 83.8 1
100,000 – 500,000 20 58.6 0.69 (0.31- 1.58) 0.393
Less than 100,000 263 106.4 1.27 (0.63 - 2.56) 0.506
WHO disease stage
Stage 4 2 24.5 1
Stage 3 38 73.9 2.91 (0.73-12.1) 0.140
Stage 2 151 94.7 3.74 (0.93-15.1) 0.064
Stage 1 152 82.5 3.25 (0.81-13.1) 0.097
Spouse status
Positive 214 97.2 1
Negative 15 140.5 1.44 (0.86 -2.44) 0.167
Unknown to woman 71 143.9 1.46 (1.13 – 1.93) 0.004*
Family planning use
No modern FP 339 134.9 1
Ever used modern FP 70 31.4 0.23 (0.18- 0.30) <0.001*
ARV
Use 297 90.6 1
No use 165 91.5 1.01 (0.83-1.22) 0.418
*Significant at 0.05 level.
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Figure 3 Kaplan Meier survival curve to show incidence of pregnancy by use of family planning among women of reproductive age
attending Mbarara ISS clinic, western Uganda.
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ciated with more fertility desire. Among the youth in
urban United States, HIV serostatus did not diminish the
fertility desires of the female youth [31] but studies of this
nature have not been conducted in Africa.
Widowed or separated women were less likely to be-
come pregnant compared to those who were single or
married. This finding is also consistent with earlier stud-
ies in Africa that have shown that widowed or divorced
women had difficulty remarrying because they were
afraid of infecting their new partners [28,32]. Women
who did not know their spouse’s HIV serostatus were
more likely to become pregnant compared to those who
knew. Also, disclosure was not related to incidence of
pregnancy. The finding contradicts other studies that
show disclosure is associated with higher incidence of
pregnancy [23]. Instead, lack of knowledge of spouse
HIV status was associated with higher incidence of preg-
nancy. A significant proportion of the women in our
data set had missing disclosure status and this may have
contributed to the null findings. However, disclosure has
been associated with positive outcomes such as partici-
pation in PMTCT programs [33] and therefore should
be encouraged using couple counseling approaches.
We were not able to measure fertility desire in this
study since our data is obtained from a database de-
signed to track patients in a routine care and treatment
program. Therefore, we are not able to establish whether
the higher likelihood of pregnancy among women of a
lower socio economic status is attached to a higher fer-
tility desire, or whether these pregnancies are mostly un-
wanted. Future studies should address this question.Women who have fewer children were more likely to
become pregnant compared to women who had more.
Prior studies in sub Saharan Africa have shown that re-
ported death of a child or a history of spontaneous abor-
tion were associated with a higher desire to get pregnant
[26,34,35], however our study was not able to collect these
variables as predictors. It is not clear what the impact of
number of HIV positive children would have as our data
on HIV positive children was not reliable for use in this
analysis. We would expect that mothers who have HIV
positive children may be motivated to want to have an-
other child with the hope the child will be negative.
Larger increases in CD4 count were associated with
lower probability of pregnancy. The observation could not
be due to reverse causality as pregnancy itself does not con-
tribute to HIV disease progression [20,36-38]. Women who
had ever used any modern family planning method during
the follow up period were less likely to become pregnant.
The prevalence of contraceptive use was however very low
at 37%. Our data did not capture the specific types of family
planning such as condoms or hormonal contraceptive
methods and hence we are not able to establish the pre-
dominant methods being used at the clinic. However a
study done at this clinic showed higher prevalence of
contraceptive use particularly among women receiving
ART compared to those not on treatment and also more
likely to use the barrier methods of contraception [39].
Our study has shed light on the increasing incidence of
pregnancy at a treatment center at a large urban clinic in
Uganda, but it has several weaknesses. First, we dropped
31% of the data because the mothers’ pregnancy records
were missing from the data set. However, we have no
Table 4 Rates of pregnancy per 1000 person years with crude Hazard ratios for the predictor variables
Variable Pregnancies per year Rates/1000 PY Crude HR (95% CI) p-value
Calendar year
2006 4 29.9 1
2007 42 52.8 1.77 (0.63 – 4.92) 0.277
2008 127 87.4 2.92 (1.08- 7.91) 0.035*
2009 190 100.7 3.36 (1.25 – 9.07) 0.016*
2010 99 122.6 4.10 (1.5-11.15) 0.006
Year of enrollment
2006 75 63.5 1
2007 175 91.3 1.43 (1.09 – 1.88 0.009*
2008 136 100 1.57 (1.19 – 2.08) 0.002*
2009 76 125.7 1.97 ( 1.43-2.7) <0.0001*
2010 0
Disclosure
No 29 77 1
Yes 126 102 1.33 (0.89–1.99) 0.160
Missing 307 88.1 1.14 (0.78 – 1.68) 0.485
Children alive
5 and above 274 93.5 1
2 - 4 children 116 72.7 0.78 (0.63 – 0.97) 0.023*
1 child 72 128.5 1.37 (1.06 - 1.78) 0.016*
Weight (kg)
Less than 50 71 65.1 1
50 -60 201 97.4 1.49 (1.14-1.96) 0.004*
61 -71 110 93.3 1.43 (1.063-1.93) 0.018*
Above 71 47 72.6 1.11 (0.77 – 1.61) 0.56
CD4 cell count at enrollment
Less than 100 57 77.85 1
100 – 250 113 97.74 1.21 (0.88-1.66) 0.233
251 – 350 74 98 1.21 (0.86-1.72) 0.265
Greater than 350 185 78 0.97 (0.72-1.35) 0.854
Difference in CD4 between most
recent and enrollment counts
Less than 100 58 243.7 1
100 – 250 8 72.9 0.29 (0.14-0.62) 0.001*
251 - 350 2 45.2 0.18 (0.45- 0.76) 0.019*
Greater than 350 394 84.1 0.34 (0.26 - 0.45) <0.0001*
*Significant at 0.05 level.
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http://www.reproductive-health-journal.com/content/11/1/81reason to believe this could have biased the analyses sig-
nificantly since the demographics of these mothers with
missing records were similar to those retained in the ana-
lysis. Second, we did not collect data on fertility intentions
and also lacked specific data on use of the types of contra-
ceptive methods vis-à-vis barrier and hormonal
methods. Thirdly pregnancy was not always confirmed
with urine HCG but was determined by history andclinical examination on subsequent visits and also, it
was not possible to establish the exact dates when preg-
nancy was first noted from the data set, especially given
that our patients do not visit the clinic at even time in-
tervals. Lastly, our analysis does not address pregnancy
outcomes and or the subsequent pregnancies that oc-
curred during the follow up period. Future studies
should be conducted to explore these issues.
Kabami et al. Reproductive Health 2014, 11:81 Page 10 of 11
http://www.reproductive-health-journal.com/content/11/1/81The strength of this paper is that we are able to effi-
ciently use routinely collected data to demonstrate
trends in incidence of pregnancy among women receiv-
ing ART in at a large clinic. Our work is among the few
papers that have demonstrated an increase in incidence
of pregnancy.
In conclusion, caregivers should integrate reproductive
health services should into HIV clinics to cater for the
needs of these women. The reproductive health counsel-
ing will likely need to involve the spouses as well. Also,
carefully designed prospective studies should be con-
ducted to show the relation between fertility intentions
and practice related to the first pregnancy after ART has
started but also for subsequent or repeat pregnancies.
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